Comparison of train-of-four and best clinical assessment during continuous paralysis

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 5, 1997, Pages 1556-1561

  Strange, Charlie ^a   Vaughan, Leigh ^a,b   Franklin, Cheryl ^a   Johnson, Jim ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Dura Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HUMAN; INTENSIVE CARE; LUNG EMBOLISM; MALE; NEUROMUSCULAR BLOCKING; PARALYSIS; PATIENT MONITORING; PRIORITY JOURNAL;

EID: 0030656513     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.5.9701079     Document Type: Article

References (35)

1. Hansen-Flaschen, J. H., S. Brazinsky, C. Basile, and P. N. Lanken. 1991. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure: a national survey. J.A.M.A. 266:2870-2875.
2. Ali, H. H. 1981. Twitch, tetanus, and train-of-four as indices of recovery from nondepolarizing neuromuscular blockade. Anesthesiology 52: 294-297.
3. Segredo, V., J. E. Calwell, M. A. Matthay, M. L. Sharma, L. D. Gruenke, and R. D. Miller. 1992. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N. Engl. J. Med. 327:524-528.
4. Hansen-Flaschen, J., J. Cowen, and E. C. Raps. 1993. Neuromuscular blockade in the intensive care unit: more than we bargained for. Am. Rev. Respir. Dis. 147:234-236.
5. Shapiro, B. A., J. Warren, A. B. Egol, D. M. Greenbaum, J. Jacobi, S. A. Nasraway, R. M. Schein, A. Spevetz, and J. R. Stone. 1995. Practice parameters for sustained neuromuscular blockade in the adult critically ill patient: an executive summary. Crit. Care Med. 23:1601-1605.
6. Frankel, H., J. Jeng, E. Tilly, A. St. Andre, and H. Champion. 1996. The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit. Am. Surg. 62:503-506.
7. Prielipp, R. C., D. B. Coursin, P. E. Scuderi, D. L. Bowton, S. R. Ford, V. J. Cardenas, J. Vender, D. Howard, E. J. Casale, and M. J. Murray. 1995. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth. Analg. 81:3-12.
8. Viby-Mogensen, J. 1993. Monitoring neuromuscular function in the intensive care unit. Intensive Care Med. 19:S74-S79.
9. Kleinpell, R., C. Bedrosian, L. McCormick, M. Kremer, L. Bujalski, and R. Bronsted. 1996. Use of peripheral nerve stimulators to monitor patients with neuromuscular blockade in the ICU. Am. J. Crit. Care 5:449-454.
10. Sgalio, T. 1995. Monitoring the administration of neuromuscular blockade in intensive care. Crit. Care Nurs. Q. 18:41-59.
11. Brull, S., and D. G. Silverman. 1995. Real time versus slow-motion train-of-four monitoring: a theory to explain the inaccuracy of visual assessment. Anesth. Analg. 80:548-551.
12. Helbo-Hansen, H., U. Bang, H. K. Nielsen, and L. T. Skovgaard. 1992. The accuracy of train-of-four monitoring at varying stimulating currents. Anesthesiology 76:199-203.
13. Tschida, S. J., L. L. Loey, and K. V. Bryan. 1995. Inconsistency with train-of-four monitoring in a critically ill paralyzed patient. Pharmacotherapy 15:540-545.
14. Orko, R. 1985. Does peripheral neuropathy disturb monitoring of neuromuscular function? Anaesthesia 40:382-383.
15. Miller, L. R., J. L. Benumof, L. Alexander, C. A. Miller, and D. Stein. 1989. Completely absent response to peripheral nerve stimulation in an acutely hypothyroid patient. Anesthesiology 71:779-781.
16. Hill, L. 1995. Peripheral electrical stimulation: titrating neuromuscular blocking agent levels. Dimens. Crit. Care Nurs. 14:305-314.
17. Engbaek, J., D. Østergaard, J. Viby-Mogensen, and L. T. Skovgaard. 1989. Clinical recovery and train-of-four ratio measured mechanically and electromyographically following atracurium. Anesthesiology 71: 391-395.
18. Klessig, H. T., J. Geiger, M. J. Murray, and D. B. Coursin. 1992. A national survey on the practice patterns of anesthesiologist intensivists in the use of muscle relaxants. Crit. Care Med. 20:1341-1345.
19. Loper, K. A., S. Butler, M. Nessly, and L. Wild. 1989. Paralyzed with pain: the need for education. Pain 37:315-316.
20. 1997. Physicians' Desk Reference, Vol. 51. Medical Economics Co., Montvale, NJ. 1155-1158.
21. Yate, P. M., P. J. Flynn, R. W. Arnold, B. C. Weatherby, R. J. Simmonds, and T. Dopson. 1987. Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive care unit. Br. J. Anaesth. 59:211-217.
22. Coursin, D. B., G. Klasek, and S. L. Goelzer. 1989. Increased requirements for continuously infused vecuronium in critically ill patients. Anesth. Analg. 69:518-521.
23. Kohlschutter, B., H. Baur, and R. Roth. 1976. Suxamethonium-induced hyperkalemia in patients with severe intra-abdominal infections. Br. J. Anaesth. 48:557-561.
24. Tschida, A. J., L. L. Hoey, A. Nahum, and K. Vance-Bryan. 1995. Atracurium resistance in a critically ill patient. Pharmacotherapy 15:533-539.
25. Bowman, W. C. 1993. Physiology and pharmacology of neuromuscular transmission, with special reference to the possible consequences of prolonged blockade. Intensive Care Med. 19:S45-S53.
26. Shelly, M. P., L. Mendel, and G. R. Park. 1987. Failure of critically ill patients to metabolize midazolam. Anaesthesia 42:619-626.
27. Karlawish, J. H. T., and J. B. Hall. 1996. The controversy over emergency research: a review of the issues and suggestions for a resolution. Am. J. Respir. Crit. Care Med. 153:499-506.
28. 1996. Federal Register 61, No. 192:§150.24.
29. Witt, N. J., D. W. Zochodyne, C. F. Bolton, F. G. Maison, G. Wells, B. Young, and W. Sibbald. 1991. Peripheral nerve function in sepsis and multiple organ failure. Chest 99:176-184.
30. Bolton, C. F. 1993. Neuromuscular complications of sepsis. Intensive Care Med. 19:S58-S59.
31. Knox, A. J., B. H. Mascie-Taylor, and M. F. Muers. 1986. Acute hydrocortisone myopathy in acute severe asthma. Thorax 41:411-412.
32. Manthous, C. A., and W. Chatila. 1994. Prolonged weakness after the withdrawal of atracurium. Am. J. Respir. Crit. Care Med. 150:1441-1443.
33. Branney, S. W., J. B. Haenel, F. A. Moore, B. B. Tarbox, R. H. Schreiber, and E. E. Moore. 1994. Prolonged paralysis with atracurium infusion: a case report. Crit. Care Med. 22:1699-1701.
34. Meyer, K. C., R. C. Prielipp, J. E. Grossman, and D. B. Coursin. 1994. Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth. Analg. 78:772-774.
35. Pollard, B. J. 1993. Neuromuscular blocking agents in intensive care. Intensive Care Med. 19:S36-S39.